Keyword search
Filter results by
Search HelpKeyword(s)
Subject
Survey or statistical program
Results
All (2)
All (2) ((2 results))
- Articles and reports: 88-003-X20030026570Geography: CanadaDescription:
In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?
Release date: 2003-06-27 - Articles and reports: 88-003-X20030016468Geography: CanadaDescription:
New small firms with more long-term debt in their balance sheets tend to devote a smaller percentage of their investment expenditure to research and development. A recent Statistics Canada study on financing innovation in new small firms provides insight into an important segment of the small-firm population, namely successful entrants.
Release date: 2003-02-18
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (2)
Analysis (2) ((2 results))
- Articles and reports: 88-003-X20030026570Geography: CanadaDescription:
In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?
Release date: 2003-06-27 - Articles and reports: 88-003-X20030016468Geography: CanadaDescription:
New small firms with more long-term debt in their balance sheets tend to devote a smaller percentage of their investment expenditure to research and development. A recent Statistics Canada study on financing innovation in new small firms provides insight into an important segment of the small-firm population, namely successful entrants.
Release date: 2003-02-18
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: